Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Bringing Hope to People Living with Neurodegenerative Diseases

Alpha Cognition Inc. ( TSX-V.ACOG , OTCMKTS: ACOGF , Forum ) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases. Stockhouse Media’s Dave Jackson caught up recently with Company CE...
Dave Jackson | October 20, 2021 |

Profiting from Protection: The Power of Permission-Based Partner Programs

(Click image to play podcast) Savvy investors know that lot of smart money is now funnelling into forward-thinking companies that are fulfilling an immediate need to provide real world solutions to identity fraud and creating value through data validation. ...
Dave Jackson | August 28, 2020 |

An Emerging Medical Market Play with Great Opportunity

(Image via Bioasis Technologies Inc.) Biopharmaceutical Company Bioasis Technologies Inc. ( TSX-V: BTI , OTCQB: BIOAF , Forum ) is developing its proprietary xB 3TM platform technology to deliver therapeutics across the blood brain barrier (BBB) and int...
Stockhouse Editorial | July 28, 2020 |

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...
Dave Jackson | December 17, 2020 |

Valeo Pharma, CureVac, Moderna, Sartorius: high-flyers or latecomers?

The pandemic continues to spread: Germany is now facing a complete lockdown. Meanwhile, there is good news from the vaccine and drug manufacturers. There are several vaccines available, and from 2021 onwards, vaccination programs are to be implemented rapidly in all industrial...
Nico Popp | December 9, 2020 |

Barrick, First Majestic, Osino Resources, Scottie Resources - preparing for helicopter money

In the 1960s, the Nobel Prize winner Milton Friedman, an influential economist in the USA, studied various models of monetary policy. One of the models of how the Federal Reserve can boost consumption and achieve its inflation targets while preventing deflation would be by iss...
Mario Hose | March 18, 2020 |

How photonics hardware is powering ChatGPT and the AI revolution

The AI market is red hot in 2023. For the technology to remain in high demand in the years ahead it will need to deliver more efficient and affordable solutions. Photonics-enabled hardware is essential for that progress. It’s easy to argue that the rea...
Research | July 20, 2023 |

Stocks to Watch: DynaCERT Inc. poised for exponential move

The level of interest for dynaCERT’s award winning HydraGEN (HG) technology is building globally as a solution to the problem of harmful exhaust emissions plaguing cities across the world. It appears only a matter of time before the demand growth cu...
Fredrick William | July 9, 2019 |

Catasys: This Is Bigger Than You Think

Sometimes big news falls on deaf ears. Which, by the way, is one of the reasons I like the micro-cap space. With only a few analysts, if any, focused on a company, meaningful news can often be overlooked for days or weeks. What happened July 23 in Catasys Inc. (CATS:OTCB...
Streetwise Reports | July 29, 2019 |

Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus

The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is because of high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany’s economic condit...
André Will-Laudien | April 24, 2024 |
1 2 3 4 5 6 7 8 9 10 ...